People with Down syndrome are likely to develop Alzheimer’s disease at a young age, with autopsy studies showing that by age 40 years, the brains of individuals with Down syndrome have amyloid plaques.
Cyclin Dependent Kinase 4 drugs in development by Therapy Areas, Indications, Stages, MoA, RoA, Molecule Type, and Key Players, 2024
The report also covers products from therapy areas such as Oncology, Infectious Disease, Toxicology, and Genetic Disorders which include the indications Solid Tumor, Human Epidermal